blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0828505

EP0828505 - USE OF ANGIOTENSIN II TYPE 2 RECEPTOR AGONISTS IN TISSUE REPAIR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.07.2004
Database last updated on 11.09.2024
Most recent event   Tooltip16.07.2004Application deemed to be withdrawnpublished on 01.09.2004  [2004/36]
Applicant(s)For all designated states
UNIVERSITY OF SOUTHERN CALIFORNIA
University Park Campus
Los Angeles, CA 90089 / US
[1998/12]
Inventor(s)01 / RODGERS, Kathleen E.
4403 Galeano Street
Long Beach, CA 90815 / US
02 / DIZEREGA, Gere Stodder
1270 Hillcrest Avenue
Pasadena, CA 91106 / US
[1998/12]
Representative(s)Van Malderen, Joëlle, et al
pronovem - Office Van Malderen
Avenue Josse Goffin 158
1082 Bruxelles / BE
[N/P]
Former [1998/12]Van Malderen, Joelle, et al
Office Van Malderen, Place Reine Fabiola 6/1
1083 Bruxelles / BE
Application number, filing date96917272.506.06.1996
[1998/12]
WO1996US09747
Priority number, dateUS1995046577406.06.1995         Original published format: US 465774
[1998/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9639164
Date:12.12.1996
Language:EN
[1996/54]
Type: A1 Application with search report 
No.:EP0828505
Date:18.03.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 12.12.1996 takes the place of the publication of the European patent application.
[1998/12]
Search report(s)International search report - published on:EP12.12.1996
ClassificationIPC:A61K38/08, A61P17/02
[2003/46]
CPC:
A61K38/085 (EP,KR,US); A61P17/02 (EP,KR); A61P3/02 (EP);
A61P43/00 (EP); C07K7/14 (KR)
Former IPC [1998/12]A61K38/08
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/12]
TitleGerman:GEBRAUCH VON ANGIOTENSIN II TYP II REZEPTOR AGONISTEN ZUR GEWEBSHEILUNG[1998/12]
English:USE OF ANGIOTENSIN II TYPE 2 RECEPTOR AGONISTS IN TISSUE REPAIR[1998/12]
French:UTILISATION D'AGONISTES DU RECEPTEUR TYPE 2 DE L'ANGIOTENSINE II DANS LA REPARATION DES TISSUS[1998/12]
Entry into regional phase05.12.1997National basic fee paid 
05.12.1997Designation fee(s) paid 
05.12.1997Examination fee paid 
Examination procedure07.01.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.12.1997Examination requested  [1998/12]
19.02.2001Request for accelerated examination filed
24.04.2001Despatch of a communication from the examining division (Time limit: M06)
24.04.2001Decision about request for accelerated examination - accepted: Yes
11.10.2001Reply to a communication from the examining division
22.07.2002Despatch of a communication from the examining division (Time limit: M04)
13.11.2002Reply to a communication from the examining division
03.02.2003Despatch of a communication from the examining division (Time limit: M04)
12.06.2003Reply to a communication from the examining division
03.07.2003Despatch of a communication from the examining division (Time limit: M04)
29.08.2003Reply to a communication from the examining division
17.10.2003Communication of intention to grant the patent
28.02.2004Application deemed to be withdrawn, date of legal effect  [2004/36]
02.04.2004Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2004/36]
Fees paidRenewal fee
26.05.1998Renewal fee patent year 03
21.05.1999Renewal fee patent year 04
23.05.2000Renewal fee patent year 05
23.05.2001Renewal fee patent year 06
24.06.2002Renewal fee patent year 07
23.06.2003Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XA]WO9508565  (UNIV SOUTHERN CALIFORNIA [US]) [X] 1,4-8,11-14,16,17 * the whole document * [A] 2,3,9,10,15;
 [DA]US5015629  (DIZEREGA GERE S [US]) [DA] 1-17 * column W *;
 [DA]  - VISWANATHAN M ET AL, "EXPRESSION OF ANGIOTENSIN II AT-2 RECEPTORS IN THE RAT SKIN DURING EXPERIMENTAL WOUND HEALING.", PEPTIDES (ELMSFORD) 13 (4). 1992. 783-786, XP000601485 [DA] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1016/0196-9781(92)90187-8
 [DA]  - SPETH R C ET AL, "DISCRIMINATION OF TWO ANGIOTENSIN II RECEPTOR SUBTYPES WITH A SELECTIVE AGONIST ANALOGUE OF ANGIOTENSIN II, P-AMINOPHENYLALANINE6 ANGIOTENSIN II", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (19900629), vol. 169, no. 3, pages 997 - 1006, XP000133889 [DA] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1016/0006-291X(90)91993-3
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.